Whitehead Study Establishes Role Of DNA Methylation In The Stability Of DNA, Suggests Possible Role Of Undermethylation In Cancer

September 02, 1998

Scientists at the Whitehead Institute for Biomedical Research have established for the first time that DNA methylation, a chemical process by which cells alter how genes are read without changing the basic text, may also be responsible for maintaining the integrity of the genome, or in other words, for ensuring that the 3 billion-letter DNA code is copied accurately when cells divide.

The findings, reported in the September 3 issue of Nature, have implications for better understanding the molecular origins of cancer. These findings suggest that the early cancer cell may use reduced DNA methylation to decrease genome stability and increase the mutation rate, both of which are crucial for the development of malignant disease. The findings resolve contradictory results from previous research on the connection between methylation and cancer.

"One of the earliest hallmarks of cancer is the decreased stability of the cellular DNA, which causes genome rearrangements and mutations and sets the stage for the cell to develop malignant disease," says Dr. Rudolf Jaenisch, Member of the Whitehead Institute and senior author on this study.

"Previously, some scientists found that tumor cells exhibited diminished methylation, while others have found excess methylation. Excess methylation was linked to the silencing of tumor suppressor genes, whereas the role of diminished DNA methylation in the malignant process was obscure. Our present study shows that reduced methylation may be responsible for the decrease in genomic stability, and therefore, the increase in mutations and chromosome loss seen in the early cancer cell," says Dr. Jaenisch.

In this study, first author Dr. Richard Chen and his colleagues in Dr. Jaenisch's lab studied cultured mouse cells lacking DNA methyltransferase (MTase), the enzyme responsible for methylating DNA. Mice carrying this mutation die in the womb. However, embryonic cells carrying the mutation can survive and grow in culture, providing researchers a useful system to study methylation.

The Whitehead researchers found that these embryonic cells have a 6-10 times higher mutation rate than normal, which suggests that there may be a causal relationship between reduced methylation and genome instability. Dr. Jaenisch and colleagues found that the mutations in these cells take the form of deletions and seem to result from an increased rate of chromosomal recombination during cell division. These findings suggest that DNA methylation might ensure genome stability by ensuring that recombination doesn't take place during mitosis.

Scientists have linked changes in DNA methylation to the onset of cancer and aging as well as many critical aspects of gene regulation (eg. genomic imprinting and X-inactivation). As a result, there has been wide-spread interest in deciphering the role of DNA methylation in the cancer research community.

The study was funded in part by grants from the Swedish Medical Research Council, the Ann Fuller Fund, the Damon Runyon-Walter Winchell Foundation, and by the National Institutes of Health.
-end-


Whitehead Institute for Biomedical Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.